Hyperinsulinemia in glucose intolerance: is it true?

Area of Science:

• Endocrinology
• Metabolic Disorders
• Diabetes Research

Background:

• Glucose intolerance is a spectrum of metabolic dysregulation.
• The role of beta-cell function in the early stages of glucose intolerance is debated.
• Understanding beta-cell response independent of fasting glycemia is crucial for early diabetes detection.

Purpose of the Study:

• To determine if beta-cell hyperfunction is a hallmark of glucose intolerance states, irrespective of fasting glucose levels.
• To investigate the relationship between glucose tolerance categories and pancreatic beta-cell function (insulin and C-peptide secretion).

Main Methods:

• A case-control study involving 430 subjects classified into normal glucose tolerance (NGT), nondiagnostic tolerance (NDT), and impaired glucose tolerance (IGT) groups.
• Matched analysis comparing NGT, NDT, and IGT subjects based on age, sex, BMI, WHR, fasting glucose, and HbA1c.
• Experimental induction of mild hyperglycemia in normal subjects to match NDT and IGT fasting glucose levels for comparative analysis.

Main Results:

• In the matched case-control study, no significant differences in fasting C-peptide levels were observed across NGT, NDT, and IGT groups at similar fasting glucose levels (5.2-5.5 mmol/L).
• Triglyceride levels and blood pressure were also similar between groups when matched for glycemia.
• Normal glucose-tolerant subjects, when made hyperglycemic, exhibited significantly higher fasting C-peptide levels compared to NDT and IGT subjects at the same fasting glucose concentration.

Conclusions:

• Beta-cell hyperfunction does not appear to be an intrinsic characteristic of glucose intolerance states independent of fasting glycemia.
• The observed data suggest that impaired beta-cell function might be present even in early stages of glucose dysregulation.
• Further research is needed to elucidate the complex interplay between beta-cell function and varying degrees of glucose tolerance.